In people with progressive MS, smaller brain volumes and abnormal thalamus connections are linked to lower fitness and less physical activity, suggesting brain changes relate to real-world function.
People with progressive MS had smaller brain volumes than similar healthy people, which means some brain tissue is lost. The thalamus, a deep brain area that helps pass signals, showed weaker connections inside itself and with nearby brain areas. The thalamus showed stronger-than-normal connections with the hippocampus, a brain area involved in memory, and this stronger link was tied to lower light physical activity. Lower cardiorespiratory fitness (measured as peak oxygen use during exercise) was linked to less white matter in the brain, which is like the brain's wiring. Overall, the study suggests fitness and daily movement relate to specific brain changes in progressive MS, linking how the brain is wired to how much people move and how fit they are.
People with progressive MS and their caregivers should care because the findings suggest that brain changes relate to real-life abilities like moving and exercise—so keeping active might matter for the brain as well as the body. Healthcare providers and therapists can use this information to focus on fitness and activity as part of care plans, since lower fitness linked to more brain tissue loss. Think of the brain like a city's road map: when roads (white matter) shrink, getting around (moving and thinking) becomes harder; staying active may help keep those roads in better shape. Rehabilitation teams might monitor thalamus connections in future as one way to see if exercise or treatments are helping. These results help explain why encouraging safe, regular activity and fitness could be an important part of daily MS care.
This study shows links but cannot prove that low activity or fitness causes the brain changes or vice versa, so we can't say exercise will definitely reverse these findings. The brain scans and activity measures were taken at one time, so we don’t know how things change over months or years for each person. The results come from people with progressive MS and a specific study group, so findings might not apply exactly the same to everyone with MS.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.